Aethlon Medical Prepares For Phase 1 Cancer Treatment Studies
Portfolio Pulse from Benzinga Newsdesk
Aethlon Medical is preparing for Phase 1 clinical trials of its Hemopurifier® for cancer treatment. The trials will include patients with solid tumors who have stable or progressive disease during anti-PD-1 monotherapy treatment, such as Keytruda® or Opdivo®. Clinical sites have started submissions for ethics committee review.
June 03, 2024 | 12:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Aethlon Medical is preparing for Phase 1 clinical trials of its Hemopurifier® for cancer treatment, targeting patients with solid tumors. Clinical sites have started submissions for ethics committee review.
The initiation of Phase 1 clinical trials is a significant milestone for Aethlon Medical, indicating progress in their product development. This could positively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100